Evidence map›Paper›PMID 32350036›Full record

ArticleLife science alliance2020

Correction: Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain.

Camilla To Benfield, Farrell MacKenzie, Markus Ritzefeld, Michela Mazzon, Stuart Weston, Edward W Tate, Boon Han Teo, Sarah E Smith, Paul Kellam, Edward C Holmes and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Life science alliance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Camilla To BenfieldDepartment of Pathobiology and Population Sciences, Royal Veterinary College, University of London, London, UK.ORCID 0000-0001-7851-4181
Farrell MacKenzieMRC Laboratory for Molecular Cell Biology, University College London, London, UK.
Markus RitzefeldDepartment of Chemistry, Imperial College London, London, UK.
Michela MazzonMRC Laboratory for Molecular Cell Biology, University College London, London, UK.ORCID 0000-0002-2462-9925
Stuart WestonMRC Laboratory for Molecular Cell Biology, University College London, London, UK.
Edward W TateDepartment of Chemistry, Imperial College London, London, UK.ORCID 0000-0003-2213-5814
Boon Han TeoDepartment of Pathobiology and Population Sciences, Royal Veterinary College, University of London, London, UK.
Sarah E SmithKymab Ltd, The Bennet Building (B930), Babraham Research Campus, Cambridge, UK.
Paul KellamDepartment of Infectious Disease, Imperial College Faculty of Medicine, Wright Fleming Institute, St Mary's Campus, London, UK.ORCID 0000-0003-3166-4734
Edward C HolmesMarie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Mark MarshMRC Laboratory for Molecular Cell Biology, University College London, London, UK.ORCID 0000-0002-0213-3259

Funding

Medical Research Council MC_UU_00012/1Medical Research Council MR/K015826/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32350036
PMCPMC7195047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.